Kyorin to Transfer Pekiron to Galderma

October 11, 2012
Kyorin Holdings announced October 9 that its subsidiary Kyorin Pharmaceutical has concluded an asset transfer agreement with Galderma SA of Switzerland for Pekiron Cream 0.5% (amorolfine HCl), a topical antifungal agent licensed from Roche of Switzerland. Kyorin Pharmaceutical will focus...read more